Page 1 | Search Results | Blood Advances | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Jessie L Alexander, Blachy J. Dávila Saldaña, Ruta Brazauskas, Sravya Gethika Dammalapati, Linda M Griffith, Ami J. Shah, Kristin A Shimano, Hans D Ochs, Jack Bleesing, Christen L Ebens, Malika Kapadia, Andrea Bauchat, Neena Kapoor, Joseph H. Oved, Hesham Eissa, Hannah Lust, Michael D. Keller, Hilary Haines, Shanmuganathan Chandrakasan, Julie-An M. Talano, Ahmad Rayes, Lisa M. Madden, Evan B. Shereck, Holly K Miller, Lisa R Forbes Satter, Caridad A. Martinez, Jacob Rozmus, Jeffrey J Bednarski, Lolie C Yu, Deepakbabu Chellapandian, Victor M. Aquino, Alan P Knutsen, Hey Chong, Ashley Chopek, Alfred P Gillio, Avni Joshi, Hemalatha G. Rangarajan, Theodore B Moore, Jeffrey R. Andolina, Kenneth DeSantes, Mark T Vander Lugt, Susan E Prockop, David Shyr, Kathleen E. Sullivan, Suhag H Parikh, Katja G. Weinacht, Troy R. Torgerson, Rebecca A Marsh, Christopher C Dvorak, Alice Y Chan, Elie Haddad, Jennifer Heimall, Michael A. Pulsipher, Jennifer W Leiding, Donald B. Kohn, Jennifer M Puck, Luigi D Notarangelo, David J Rawlings, Morton J Cowan, Aleksandra Petrovic, Sung-Yun Pai, Lauri M. Burroughs

Blood Adv bloodadvances.2025017662.

https://doi.org/10.1182/bloodadvances.2025017662

Published: 2025

Includes: Supplemental data

Journal Articles

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH study

Blood Adv bloodadvances.2024013690.

https://doi.org/10.1182/bloodadvances.2024013690

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTC

Ahmad Rayes, Brent R. Logan, Xuerong Liu, Jasmeen Dara, Rebecca H. Buckley, Joseph H. Oved, Neena Kapoor, Malika Kapadia, Sharat Chandra, Caridad A. Martinez, Nancy Bunin, Shanmuganathan Chandrakasan, Karin Chen, Jeffrey J Bednarski, Hilary L. Haines, Hesham Eissa, Julie-An M. Talano, Michael D. Keller, Christen L Ebens, Sonali Chaudhury, Evan B. Shereck, Victor M. Aquino, Alan P Knutsen, Jessie L Alexander, Alfred P Gillio, Deepakbabu Chellapandian, Ami J. Shah, Holly K Miller, Mark T Vander Lugt, Christine M. Seroogy, Morna J. Dorsey, Talal Mousallem, Roberta Essom Parrott, Richard J O'Reilly, Paibel I. Aguayo-Hiraldo, Susan E Prockop, Blachy J. Dávila Saldaña, Monica S. Thakar, Lauri M. Burroughs, Troy R. Torgerson, Jennifer W Leiding, Rebecca A Marsh, Linda M Griffith, Michael A. Pulsipher, Donald B. Kohn, Luigi D Notarangelo, Morton J Cowan, Jennifer M Puck, Geoffrey D.E. Cuvelier, Jennifer Heimall, Elie Haddad, Sung-Yun Pai, Christopher C Dvorak

Blood Adv bloodadvances.2025016812.

https://doi.org/10.1182/bloodadvances.2025016812

Published: 2025

Includes: Supplemental data

Journal Articles

Breaking the cycle: PRMTs and secondary HLH relief

Sakshi Malik, Shanmuganathan Chandrakasan

Blood Adv (2025) 9 (10): 2436–2437.

https://doi.org/10.1182/bloodadvances.2025015863

Published: 2025

Journal Articles

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

Blood Adv (2025) 9 (8): 1952–1965.

https://doi.org/10.1182/bloodadvances.2024014391

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab

Blood Adv (2024) 8 (9): 2248–2258.

https://doi.org/10.1182/bloodadvances.2023012217

Published: 2024

Includes: Supplemental data

Journal Articles

HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh

Shanmuganathan Chandrakasan, Sharat Chandra, Chengyu Prince, Lisa J. Kobrynski, Laura Lucas, Kiran Patel, Jolan Walter, Rebecca H. Buckley, Roland Meisel, Sujal Ghosh, Suhag H. Parikh

Blood Adv (2022) 6 (12): 3751–3755.

https://doi.org/10.1182/bloodadvances.2021006905

Published: 2022

Includes: Supplemental data

Journal Articles

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation

Sanyukta Janardan, Edwin Horwitz, Benjamin Watkins, Kirsten Williams, Shanmuganathan Chandrakasan, Muna Qayed, Suhag Parikh, Staci Arnold, Frank Keller, Adina Alazraki, Michelle Schoettler, Kathryn Leung

Blood Adv (2022) 6 (10): 3058–3061.

https://doi.org/10.1182/bloodadvances.2021006535

Published: 2022

Journal Articles

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

Blood Adv (2022) 6 (2): 452–459.

https://doi.org/10.1182/bloodadvances.2021005291

Published: 2022

Includes: Supplemental data

Journal Articles

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

Blood Adv (2020) 4 (23): 6039–6050.

https://doi.org/10.1182/bloodadvances.2020003334

Published: 2020

Includes: Supplemental data

Journal Articles

Rituximab leads to early elimination of circulating CD20 + T and B lymphocytes in patients with iTTP despite ongoing TPEx

Marcus A. Carden, Manila Gaddh, Abhinav Hoskote, Michael Brown, Virginia Merrill, Sean R. Stowell, Shanmuganathan Chandrakasan, Ana Antun, Ragini Kudchadkar, Sarah Kotanchiyev, David L. Jaye, Imre Bodó

Blood Adv (2020) 4 (3): 477–481.

https://doi.org/10.1182/bloodadvances.2019001148

Published: 2020

Includes: Supplemental data

Journal Articles

Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF–mobilized stem cell transplantation

Edmund K. Waller, Brent R. Logan, Mingwei Fei, Stephanie J. Lee, Dennis Confer, Alan Howard, Shanmuganathan Chandrakasan, Claudio Anasetti, Shanelle M. Fernando, Cynthia R. Giver

Blood Adv (2019) 3 (15): 2250–2263.

https://doi.org/10.1182/bloodadvances.2018029892

Published: 2019

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH study

Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTC

Breaking the cycle: PRMTs and secondary HLH relief

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab

HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

Rituximab leads to early elimination of circulating CD20 + T and B lymphocytes in patients with iTTP despite ongoing TPEx

Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF–mobilized stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only